SPOTLIGHT -
EP. 1: Systemic Therapy in Newly Diagnosed Pancreatic Cancer
EP. 2: Deciding Among Frontline Standards of Care in Pancreatic Cancer
EP. 3: Dose Modification Rationale in Advanced Pancreatic Cancer
EP. 4: Clinical Trial Results of MM-398 in Pancreatic Cancer
EP. 5: Impact of MM-398 on Sequencing Decisions in Pancreatic Cancer
EP. 6: QOL Considerations in Advanced Pancreatic Cancer
EP. 7: Role of Surgery in Locally Advanced Pancreatic Cancer
EP. 8: Neoadjuvant Therapy in Resectable Pancreatic Cancer
EP. 9: Advanced Pancreatic Cancer: Options in the Adjuvant Setting
EP. 10: Emerging Immunotherapy Data in Pancreatic Cancer
EP. 11: Molecular Profiling in Pancreatic Cancer
EP. 12: Early Phase Clinical Trials in Pancreatic Cancer
EP. 13: Advanced Pancreatic Cancer: A Look Ahead
Further Understanding of Immune Mechanisms in Tumor Microenvironment Is Key to Advancing Immunotherapy in Solid Tumors
Navigating Systemic Therapy for RCC: Balancing Risk Status and Response
ADCs, Novel Targets Represent Next Wave of Treatment Advances in mCRPC
Precision Medicine in Prostate Cancer Care: Keeping Up With Evolving Guidance for Testing and Decision Making
